Evidence map›Paper›PMID 24690158›Full record

ArticleEpilepsy research2014

Tumor associated seizures in glioblastomas are influenced by survival gene expression in a region-specific manner: a gene expression imaging study.

Jong Woo Lee, Andrew D Norden, Keith L Ligon, Alexandra J Golby, Rameen Beroukhim, John Quackenbush, William Wells, Kristen Oelschlager, Derek Maetzold, Patrick Y Wen

Open access · greenAbstract read
In one paragraph

Article in Epilepsy research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. The molecular landscape of glioblastoma-associated epilepsy.Journal of molecular medicine (Berlin, Germany) · 2025
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. What is New in the Management of Epilepsy in Gliomas?Current treatment options in neurology · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Jong Woo LeeDepartment of Neurology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, United States. Electronic address: jlee38@partners.org.
Andrew D NordenCenter for Neuro-oncology, Dana Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02115, United States.
Keith L LigonDepartment of Pathology, Brigham and Women's Hospital, Boston Children's Hospital, and Harvard Medical School, 75 Francis Street, Boston, MA 02115, United States; Department of Medical Oncology, Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02115, United States.
Alexandra J GolbyDepartment of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, United States.
Rameen BeroukhimCenter for Neuro-oncology, Dana Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02115, United States.
John QuackenbushDepartment of Biostatistics, Dana Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02115, United States.
William WellsDepartment of Radiology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA, United States.
Kristen OelschlagerCastle Biosciences Inc., 3330N 2nd Street, Suite 207, Phoenix, AZ 85012, United States.
Derek MaetzoldCastle Biosciences Inc., 3330N 2nd Street, Suite 207, Phoenix, AZ 85012, United States.
Patrick Y WenCenter for Neuro-oncology, Dana Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02115, United States.
Brigham and Women's Hospital · USHarvard University · US

Funding

WHITE MATTER ARCHITECTURE FROM DT-MRIP41RR013218 · NCRR · BRIGHAM AND WOMEN'S HOSPITAL · PI KIKINIS, RON · 1998 to 2011
$30.6M
Training and DisseminationP41EB015902 · NIBIB · BRIGHAM AND WOMEN'S HOSPITAL · PI PUJOL, SONIA · 2012 to 2022
$20.9M
Image Guided Therapy Center - Ultrasound-based sensor system for the monitoring of COVID-19 patientsP41EB015898 · NIBIB · BRIGHAM AND WOMEN'S HOSPITAL · PI TEMPANY, CLARE M · 2012 to 2021
$18.9M
ULTRASOUND THERAPY DELIVERY THROUGH INTACT SKULLU41RR019703 · NCRR · BRIGHAM AND WOMEN'S HOSPITAL · PI TEMPANY, CLARE M · 2005 to 2009
$17.2M
IMAGE GUIDED THERAPY CENTERP41RR019703 · NCRR · BRIGHAM AND WOMEN'S HOSPITAL · PI JOLESZ, FERENC A · 2010 to 2011
$8.6M
NCRR NIH HHS P41 RR013218NCRR NIH HHS P41 RR019703NCRR NIH HHS P41RR13218NCRR NIH HHS U41 RR019703NIBIB NIH HHS P41 EB015898NIBIB NIH HHS P41 EB015902
6 · The paper itself

Abstract

Tumor associated seizures (TAS) are common and cause significant morbidity. Both imaging and gene expression features play significant roles in determining TAS, with strong interactions between them. We describe gene expression imaging tools which allow mapping of brain regions where gene expression has significant influence on TAS, and apply these methods to study 77 patients who underwent surgical evaluation for supratentorial glioblastomas. Tumor size and location were measured from MRI scans. A 9-set gene expression profile predicting long-term survivors was obtained from RNA derived from formalin-fixed paraffin embedded tissue. A total of 32 patients (42%) experienced preoperative TAS. Tumor volume was smaller (31.1 vs. 58.8 cubic cm, p<0.001) and there was a trend toward median survival being higher (48.4 vs. 32.7 months, p=0.055) in patients with TAS. Although the expression of only OLIG2 was significantly lower in patients with TAS in a groupwise analysis, gene expression imaging analysis revealed regions with significantly lower expression of OLIG2 and RTN1 in patients with TAS. Gene expression imaging is a powerful technique that demonstrates that the influence of gene expression on TAS is highly region specific. Regional variability should be evaluated with any genomic or molecular markers of solid brain lesions.

Indexed as

Gene ExpressionAdultAgedAged, 80 and overBasic Helix-Loop-Helix ProteinsBrainBrain MappingBrain NeoplasmsFemaleGene Expression ProfilingGlioblastomaHumansMagnetic Resonance ImagingMaleMiddle AgedNerve Tissue ProteinsBasic Helix-Loop-Helix ProteinsNerve Tissue ProteinsOLIG2 protein, humanOligodendrocyte Transcription Factor 2RTN1 protein, humanBrain tumorGene expressionImagingSeizure

Identifiers

PMID24690158
PMCPMC4076930
OpenAlexW2145808974

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.